Cipla Ltd. et al. vs. Abraxis Biosciences, LLC et al.
Explore the PTAB proceeding IPR2018-00162 filed by Cipla Ltd. et al. on 2017-11-09. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2018-00162
Filing Date
2017-11-09
Accorded Filing Date
2017-11-17
Institution Decision Date
2018-05-08
Last Modified Date
2022-09-17
Proceeding Type
IPR
Termination Date
—
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Cipla Ltd. et al.
Represented By
Freno, Michael et alPatent Owner / Respondent
Abraxis Biosciences, LLC et al.
Represented By
Harnett, Christopher et alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
0 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 39708 | Denise Hickey | +1 858-558-7500 |
| 40130 | Catherine Polizzi | +1 650-813-5651 |
| 52285 | Shannon Reaney | +1 650-813-5600 |
| 55748 | Jian Xiao | +1 650-813-5736 |
| 70339 | John Chapman | +1 650-813-5726 |
| 73248 | Meghan Poon | +1 650-813-4108 |
| 73258 | Ethan Weiner | +1 650-813-4119 |
| 77034 | Yuying You | +1 205-240-2417 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 14 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 7,820,788 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 7,923,536 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,138,229 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,314,156 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2012028320 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,846,771 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,012,519 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,012,518 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2015016504 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 43,231,702 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 52,654,403 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 52,677,303 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 52,717,703 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2005000400 | US Continuation / Sibling | View Official Patent → |
Apotex Inc. v. Abraxis Biosciences, LLC
Cipla Ltd. et al. v. AbraxisBiosciences, LLC et al.
Cipla Ltd. et al. v. Abraxis Biosciences, LLC et al.
Apotex Inc. et al. v. Abraxis BioScience, LLC et al.
Actavis LLC v. ABRAXIS BIOSCIENCE, LLC,
Actavis LLC v. ABRAXIS BIOSCIENCE, LLC